Quick Hits:

1. Medicare Overcharge: Health insurance companies overcharged the federal government by $50 billion through misleading diagnoses under Medicare Advantage programs.
2. Fake Diagnoses for Profit: Insurers padded medical charts with fabricated illnesses like diabetic cataracts, often without patient treatment or doctor confirmation.
3. Taxpayer Impact: Medicare Advantage spending now exceeds $450 billion, accounting for more than half of Medicare's total cost—hitting taxpayers hard.

By Samuel A. Lopez, USA Herald

[USA Herald] - This latest revelation that private health insurance companies have overcharged Medicare by over $50 billion for exaggerated or fake illnesses is a shocking breach of trust.

Medicare Advantage, a program that was designed to offer seniors and disabled Americans better healthcare options through private insurers, has now turned into a costly burden for taxpayers. A Wall Street Journal investigation uncovered that private insurers inflated patient diagnoses to defraud the government for conditions patients either didn’t have or weren’t as severe as claimed. In essence, Medicare was swindled into paying for phantom ailments.

Inflated Diagnoses for Profit

The way Medicare Advantage works is simple: the government pays private insurers a set rate to cover patients. However, when a patient is diagnosed with certain costly illnesses, the payment increases significantly. For example, an insurer gets $2,370 extra for a patient with morbid obesity or $2,180 for someone diagnosed with a stroke. This incentivized insurers to dig through patient records, add extra diagnoses, and submit inflated claims—many times without the patient ever receiving treatment for these illnesses.

According to the investigation, insurers were far more likely to diagnose Medicare Advantage patients with costly conditions like morbid obesity or diabetic cataracts compared to those on traditional Medicare. The data suggests this wasn’t coincidental—it was a strategic, profit-driven move to game the system. One particularly outrageous example is how over 66,000 patients were diagnosed with diabetic cataracts—despite having already undergone surgery to cure the condition. As Dr. Hogan Knox of the University of Alabama put it, “Once a lens is removed, the cataract never comes back. It’s anatomically impossible.”

A System Exploited

The Journal’s analysis also showed that insurers often added diagnoses to patients’ records using artificial intelligence and home visits from nurses. These “diagnoses” often contradicted what the patients’ doctors had recorded. Some insurers even incentivized patients to agree to home visits with gift cards and other perks. As a result, a staggering number of Medicare Advantage patients were diagnosed with conditions that traditional Medicare patients simply didn’t have. In fact, patients enrolled in Medicare Advantage were 15 times more likely to be diagnosed with diabetic cataracts than those in traditional Medicare.

UnitedHealth Group, one of the largest Medicare Advantage providers, pushed back against the findings, claiming the Journal’s report was “inaccurate and biased.” They argued that Medicare Advantage provides better outcomes and more affordable care for millions of seniors. However, the data paints a starkly different picture. The system has become more expensive than traditional Medicare, accounting for over $450 billion in taxpayer dollars annually.

The Cost to Taxpayers

Medicare Advantage was meant to provide better care for sicker patients. Instead, it has become a money-making scheme for private insurers. The incentives to “find” more diagnoses in patients have led to ballooning costs that are now higher than traditional Medicare.

It’s an egregious example of bad faith conduct by insurers, and it raises serious ethical questions about how our healthcare system is being manipulated for profit. As someone who covers both the insurance industry and legal sector, this case underscores the importance of holding these companies accountable. When insurers prioritize profit over patient care, it’s taxpayers—and vulnerable patients—who pay the price.

In my view, this situation reflects a broader issue of trust. Our healthcare system relies on transparency and integrity, but when insurers manipulate data for financial gain, it erodes public trust in these institutions. These are the very companies that are supposed to be caring for our nation’s seniors and disabled. Instead, they’ve exploited the system, costing taxpayers billions.

"This $50 billion overcharge isn’t just a financial scandal—it's a breach of trust. We’re talking about taxpayer dollars and vulnerable patients being used as pawns in a profit-driven game. Accountability is overdue," I would say, drawing on my experience in both the legal and insurance industries.

What’s Next?

The Centers for Medicare and Medicaid Services (CMS) have pledged to implement reforms to curb these abuses. A spokeswoman for CMS stated they would continue working to ensure that “taxpayer dollars are appropriately spent,” while still providing “robust and stable options” for Medicare beneficiaries. But is this enough?

It’s clear that more oversight is needed. Insurers can’t be allowed to continue inflating patient diagnoses without consequence. The integrity of Medicare Advantage—and by extension, our healthcare system—depends on it.

For more on my work and reporting, visit my bio or check out my articles at USA Herald.